1-4 of 4
Douglas Tremblay
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CNL and aCML are prognostically distinct: a large National Cancer Database analysis

Douglas Tremblay, Dahniel Sastow, John Mascarenhas
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4400–4402.
https://doi.org/10.1182/bloodadvances.2023010722
Published: 2023
Journal Articles

Pacritinib demonstrates spleen volume reduction in patients with myelofibrosis independent of JAK2V617F allele burden

Clinical Trials & Observations
Douglas Tremblay, Ruben Mesa, Bart Scott, Sarah Buckley, Karisse Roman-Torres, Srdan Verstovsek, John Mascarenhas
Journal: Blood Advances
Blood Adv (2020) 4 (23): 5929–5935.
https://doi.org/10.1182/bloodadvances.2020002970
Published: 2020
Includes: Supplemental data
Journal Articles

The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis

Clinical Trials & Observations
Leonard Naymagon, Douglas Tremblay, Nicole Zubizarreta, Erin Moshier, Kevin Troy, Thomas Schiano, John Mascarenhas
Journal: Blood Advances
Blood Adv (2020) 4 (4): 655–666.
https://doi.org/10.1182/bloodadvances.2019001310
Published: 2020
Journal Articles

Myoclonic jerks complicating treatment of acute promyelocytic leukemia: case report and literature review

Clinical Trials & Observations
John Y. Rhee, Douglas Tremblay, Amy M. Chan, Martin S. Tallman, John Mascarenhas
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1854–1857.
https://doi.org/10.1182/bloodadvances.2019000249
Published: 2019